Skip to main content
Erschienen in: Annals of Surgical Oncology 13/2012

01.12.2012 | Breast Oncology

A Comparison of Indocyanine Green Fluorescence Imaging Plus Blue Dye and Blue Dye Alone for Sentinel Node Navigation Surgery in Breast Cancer Patients

verfasst von: Akira Hirano, MD, PhD, Mari Kamimura, MD, Kaoru Ogura, MD, Naomi Kim, MD, Akinori Hattori, MD, Yumika Setoguchi, MD, Fumie Okubo, MD, Hiroaki Inoue, MD, Reiko Miyamoto, MD, Jun Kinoshita, MD, PhD, Mariko Fujibayashi, MD, PhD, Tadao Shimizu, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 13/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate two methods of sentinel node navigation surgery (SNNS) using blue dye with and without indocyanine green (ICG) fluorescence imaging (FI) to determine the usefulness of combined ICG and blue dye.

Methods

Between 2005 and 2010, a total of 501 patients underwent SNNS in our hospital. Detection of sentinel lymph node (SLN) was performed with sulfan blue (SB) alone until 2008 and with a combination of SB and ICG-FI since 2009. ICG 5 mg and SB 15 mg were injected in the subareolar region, and FI was obtained by a fluorescence imaging device.

Results

We attempted to identify SLNs in 393 patients by SB alone and in 108 patients by a combination of SB and FI. The mean number of SLNs detected was 1.6 (0–5) for SB alone and 2.2 (1–6) for the combination method. The SLN identification rate was 95.7 % for SB alone and 100 % for the combination method so that the combination was significantly superior to SB in terms of the identification rate (p = 0.0037). In patients who received the combination method, detection of SLN was made through only SB in 1 patient, only ICG in 8 patients, and both in 99 patients. Lymph node metastasis was found in 56 patients with SB alone and in 16 patients with the combination method. Recurrence of an axillary node was observed in 3 patients (0.8 %) with SB alone and in no patients with the combination method.

Conclusions

ICG-FI is a useful method and is especially recommended in cases where no radiotracers are available.
Literatur
1.
Zurück zum Zitat Krag DN, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer—a multicenter validation study. N Engl J Med. 1988;339:941–6.CrossRef Krag DN, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer—a multicenter validation study. N Engl J Med. 1988;339:941–6.CrossRef
2.
Zurück zum Zitat Goldhirsch A, Wood WC, Galber RD, et al. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol. 2007;18:1133–44.PubMedCrossRef Goldhirsch A, Wood WC, Galber RD, et al. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol. 2007;18:1133–44.PubMedCrossRef
3.
Zurück zum Zitat Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927–33.PubMedCrossRef Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927–33.PubMedCrossRef
4.
Zurück zum Zitat Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 1998;227:645–53.PubMedCrossRef Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 1998;227:645–53.PubMedCrossRef
5.
Zurück zum Zitat Rutgers EJ. Guidelines to assure quality in breast cancer surgery. Eur J Surg Oncol. 2005;31:568–76.PubMedCrossRef Rutgers EJ. Guidelines to assure quality in breast cancer surgery. Eur J Surg Oncol. 2005;31:568–76.PubMedCrossRef
6.
Zurück zum Zitat Sanidas EE, de Bree E, Tsiftsis DD. How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer? Am J Surg. 2003;185:202–10.PubMedCrossRef Sanidas EE, de Bree E, Tsiftsis DD. How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer? Am J Surg. 2003;185:202–10.PubMedCrossRef
7.
Zurück zum Zitat Schwartz GF, Giuliano AE, Veronesi U; Consensus Conference Committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19 to 22, 2001, Philadelphia, Pennsylvania. Hum Pathol. 2002;33:579–89. Schwartz GF, Giuliano AE, Veronesi U; Consensus Conference Committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19 to 22, 2001, Philadelphia, Pennsylvania. Hum Pathol. 2002;33:579–89.
8.
Zurück zum Zitat Sanidas EE, Daskalakis M, Sbyrakis N, et al. Modifications of the learning curve guidelines for breast cancer sentinel node biopsy. Eur J Surg Oncol. 2005;31:357–63.PubMedCrossRef Sanidas EE, Daskalakis M, Sbyrakis N, et al. Modifications of the learning curve guidelines for breast cancer sentinel node biopsy. Eur J Surg Oncol. 2005;31:357–63.PubMedCrossRef
9.
Zurück zum Zitat Kitai T, Inomoto T, Miwa M, Shikayama T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer. 2005;12:211–5.PubMedCrossRef Kitai T, Inomoto T, Miwa M, Shikayama T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer. 2005;12:211–5.PubMedCrossRef
10.
Zurück zum Zitat Tagaya N, Yamazaki R, Nakagawa A, et al. Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg. 2008;195:850–3.PubMedCrossRef Tagaya N, Yamazaki R, Nakagawa A, et al. Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg. 2008;195:850–3.PubMedCrossRef
11.
Zurück zum Zitat McMasters KM, Wong SL, Martin RCG II, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg. 2001;233:676–87.PubMedCrossRef McMasters KM, Wong SL, Martin RCG II, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg. 2001;233:676–87.PubMedCrossRef
12.
Zurück zum Zitat Kang SW, Chung SE, Shin WJ, et al. Polypoidal choroidal vasculopathy and late geographic hyperfluorescence on indocyanine green angiography. Br J Ophthalmol. 2009;93:759–64.PubMedCrossRef Kang SW, Chung SE, Shin WJ, et al. Polypoidal choroidal vasculopathy and late geographic hyperfluorescence on indocyanine green angiography. Br J Ophthalmol. 2009;93:759–64.PubMedCrossRef
13.
Zurück zum Zitat Schneider PD. Preoperative assessment of liver function. Surg Clin North Am. 2004;84:355–73.PubMedCrossRef Schneider PD. Preoperative assessment of liver function. Surg Clin North Am. 2004;84:355–73.PubMedCrossRef
14.
Zurück zum Zitat Vogt PR, Bauer EP, Graves K. Novadaq SPY Intraoperative imaging system—current status. Thorac Cardiovasc Surg. 2003;51:49–51.PubMedCrossRef Vogt PR, Bauer EP, Graves K. Novadaq SPY Intraoperative imaging system—current status. Thorac Cardiovasc Surg. 2003;51:49–51.PubMedCrossRef
15.
Zurück zum Zitat Hirsche C, Murawa D, Mohr Z, Kneif S, Hunerbein M. ICG fluorescent–guided sentinel node biopsy for axillary nodal staging in breast cancer. Breast Cancer Res Treat. 2010;121:373–8.CrossRef Hirsche C, Murawa D, Mohr Z, Kneif S, Hunerbein M. ICG fluorescent–guided sentinel node biopsy for axillary nodal staging in breast cancer. Breast Cancer Res Treat. 2010;121:373–8.CrossRef
16.
Zurück zum Zitat Tagaya N, Tsumuraya M, Nakagawa A, et al. 2010 Indocyanine green (ICG) fluorescence imaging versus radioactive colloid for sentinel lymph node identification in patients with breast cancer. J Clin Oncol 28:674. Tagaya N, Tsumuraya M, Nakagawa A, et al. 2010 Indocyanine green (ICG) fluorescence imaging versus radioactive colloid for sentinel lymph node identification in patients with breast cancer. J Clin Oncol 28:674.
17.
Zurück zum Zitat Aoyama K, Kamio T, Nishizawa M, et al. Sentinel lymph node biopsy for breast cancer patients using fluorescence navigation with indocyanine green. World J Surg Oncol. 2011;9:157.PubMedCrossRef Aoyama K, Kamio T, Nishizawa M, et al. Sentinel lymph node biopsy for breast cancer patients using fluorescence navigation with indocyanine green. World J Surg Oncol. 2011;9:157.PubMedCrossRef
18.
Zurück zum Zitat Bass SS, Cox CE, Reintgen DS, et al. Learning curves and certification for breast cancer lymphatic mapping. Surg Oncol Clin N Am. 1999;8:497–509.PubMed Bass SS, Cox CE, Reintgen DS, et al. Learning curves and certification for breast cancer lymphatic mapping. Surg Oncol Clin N Am. 1999;8:497–509.PubMed
19.
Zurück zum Zitat Dupont E, Cox C, Shivers S, et al. Learning curves and breast cancer lymphatic mapping: Institutional volume index. J Surg Res. 2001;97:92–6.PubMedCrossRef Dupont E, Cox C, Shivers S, et al. Learning curves and breast cancer lymphatic mapping: Institutional volume index. J Surg Res. 2001;97:92–6.PubMedCrossRef
20.
Zurück zum Zitat Hojo T, Nagao T, Kikuyama M, et al. Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer. Breast. 2010;19:210–3.PubMedCrossRef Hojo T, Nagao T, Kikuyama M, et al. Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer. Breast. 2010;19:210–3.PubMedCrossRef
Metadaten
Titel
A Comparison of Indocyanine Green Fluorescence Imaging Plus Blue Dye and Blue Dye Alone for Sentinel Node Navigation Surgery in Breast Cancer Patients
verfasst von
Akira Hirano, MD, PhD
Mari Kamimura, MD
Kaoru Ogura, MD
Naomi Kim, MD
Akinori Hattori, MD
Yumika Setoguchi, MD
Fumie Okubo, MD
Hiroaki Inoue, MD
Reiko Miyamoto, MD
Jun Kinoshita, MD, PhD
Mariko Fujibayashi, MD, PhD
Tadao Shimizu, MD, PhD
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 13/2012
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-012-2478-0

Weitere Artikel der Ausgabe 13/2012

Annals of Surgical Oncology 13/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.